|Technology Appraisal Advisory Committee
Tuesday 28 February 2017
Dear consultees and commentators,
I am writing to inform you that the public registration facility to observe the committee meeting for everolimus, lutetium-177 DOTATATE and sunitinib for treating unresectable or metastatic neuroendocrine tumours with disease progression will open on Tuesday 31 January 2017 on the NICE website.
If you would like to register for this committee meeting, please do so via the following web page: http://www.nice.org.uk/event/tacd-february-2017 . Registration for this meeting will close on Tuesday 14 February 2017 at 5pm. Please note we may be unable to accept late requests to observe this meeting.
As a public observer, you will be able to listen to the business of the meeting, except where confidential information is being discussed, however, you will not be able to:
· participate in committee discussions
· ask questions, take part in voting or put your views to members of the committee
For further information about meetings in public please refer to the following document: Common questions and answers about meetings in public.
Should you have any queries regarding observing this meeting, please contact the Meetings in Public Coordinator, Jonathan Littler, [email protected]
Help & support:
0800 434 6476
General enquiries: 01926 883487